Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)

Cancer Science ◽

10.1111/cas.12218 ◽

2013 ◽

Vol 104 (9) ◽

pp. 1211-1216 ◽

Author(s):

Chigusa Morizane ◽

Takuji Okusaka ◽

Junki Mizusawa ◽

Atsuo Takashima ◽

Makoto Ueno ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Tract Cancer ◽

Randomized Phase Ii ◽

Download Full-text

Randomized Phase II Study of Gemcitabine plus S-1 Combination Therapy vs. S-1 in Advanced Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG0805)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq110 ◽

2010 ◽

Vol 40 (12) ◽

pp. 1189-1191 ◽

Author(s):

A. Takashima ◽

C. Morizane ◽

H. Ishii ◽

K. Nakamura ◽

H. Fukuda ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Gemcitabine Plus S-1 Combination Therapy Versus S-1 in Advanced Biliary Tract Cancer: Results of the Japan Clinical Oncology Group Study (JCOG0805)

Annals of Oncology ◽

10.1093/annonc/mds548 ◽

2012 ◽

Vol 23 ◽

pp. xi15

Author(s):

M. Ikeda ◽

T. Okusaka ◽

J. Mizusawa ◽

A. Takashima ◽

C. Morizane ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

ESMO Open ◽

10.1016/j.esmoop.2021.100314 ◽

2022 ◽

Vol 7 (1) ◽

pp. 100314

Author(s):

M.M. Javle ◽

D.-Y. Oh ◽

M. Ikeda ◽

W.-P. Yong ◽

K. Hsu ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Second Line ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy004 ◽

2018 ◽

Vol 48 (4) ◽

pp. 392-395 ◽

Author(s):

Kohei Nakachi ◽

Masaru Konishi ◽

Masafumi Ikeda ◽

Junki Mizusawa ◽

Junko Eba ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Download Full-text

Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv213 ◽

2016 ◽

Vol 46 (4) ◽

pp. 385-388 ◽

Author(s):

Junki Mizusawa ◽

Chigusa Morizane ◽

Takuji Okusaka ◽

Hiroshi Katayama ◽

Hiroshi Ishii ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Phase Iii Study

Download Full-text

A phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: the Japan Clinical Oncology Group trial (JCOG0109)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4071 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4071-4071 ◽

Author(s):

T. Hamaguchi ◽

A. Ohtsu ◽

I. Hyodo ◽

Y. Arai ◽

H. Takiuchi ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Download Full-text

A multi-center randomized phase II study of nivolumab in combination with gemcitabine/cisplatin or ipilimumab as first line therapy for patients with advanced unresectable biliary tract cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps4142 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS4142-TPS4142 ◽

Author(s):

Vaibhav Sahai ◽

Kent A. Griffith ◽

Muhammad Shaalan Beg ◽

Mark Zalupski

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

6596 POSTER A Randomized Phase II Study of Gemcitabine (GEM) Plus S-1 Combination Chemotherapy Versus GEM Monotherapy in Patients (pts) With Advanced Biliary Tract Cancer (BTC) – GS-COMBI Study

European Journal of Cancer ◽

10.1016/s0959-8049(11)71907-4 ◽

2011 ◽

Vol 47 ◽

pp. S470

Author(s):

T. Sasaki ◽

H. Isayama ◽

Y. Ito ◽

I. Yasuda ◽

N. Toda ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Combination Chemotherapy ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

AB061. P-32. Multicenter, randomized phase II trial of S-1, leucovorin, oxaliplatin and gemcitabine (SLOG) in chemo-naïve advanced biliary tract cancer: a Taiwan Cooperative Oncology Group study

HepatoBiliary Surgery and Nutrition ◽

10.21037/hbsn.2019.ab061 ◽

2019 ◽

Vol 8 (S1) ◽

pp. AB061-AB061

Author(s):

Jen-Shi Chen ◽

Li-Yuan Bai ◽

Ming-Huang Chen ◽

Nai-Jung Chiang ◽

Chiun Hsu ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Post-hoc analyses of a subgroup of patients with advanced biliary tract cancer (BTC) who crossed over to treatment with etoposide toniribate (EDO-S7.1) in a randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdz247.051 ◽

2019 ◽

Vol 30 ◽

pp. v278 ◽

Author(s):

U.-F. Pape ◽

S. Kasper ◽

J. Meiler ◽

M. Sinn ◽

A. Vogel ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

Randomized Phase Ii ◽

Download Full-text